Global Pulmonary Drugs Market Insights and Forecast to 2028

Report ID: 1802472 | Published Date: Jan 2025 | No. of Page: 109 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Pulmonary Drugs Product Introduction
    1.2 Market by Type
        1.2.1 Global Pulmonary Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Inhaled Corticosteroids
        1.2.3 Long Acting Beta-2 Agonists
        1.2.4 Antihistamines
        1.2.5 Vasodilators
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Pulmonary Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Asthma & COPD
        1.3.3 Allergic Rhinitis
        1.3.4 Pulmonary Arterial Hypertension
        1.3.5 Cystic Fibrosis
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Pulmonary Drugs Sales Estimates and Forecasts 2017-2028
    2.2 Global Pulmonary Drugs Revenue Estimates and Forecasts 2017-2028
    2.3 Global Pulmonary Drugs Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Pulmonary Drugs Sales by Region
        2.4.1 Global Pulmonary Drugs Sales by Region (2017-2022)
        2.4.2 Global Sales Pulmonary Drugs by Region (2023-2028)
    2.5 Global Pulmonary Drugs Revenue by Region
        2.5.1 Global Pulmonary Drugs Revenue by Region (2017-2022)
        2.5.2 Global Pulmonary Drugs Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Pulmonary Drugs Sales by Manufacturers
        3.1.1 Global Top Pulmonary Drugs Manufacturers by Sales (2017-2022)
        3.1.2 Global Pulmonary Drugs Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pulmonary Drugs in 2021
    3.2 Global Pulmonary Drugs Revenue by Manufacturers
        3.2.1 Global Pulmonary Drugs Revenue by Manufacturers (2017-2022)
        3.2.2 Global Pulmonary Drugs Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Pulmonary Drugs Revenue in 2021
    3.3 Global Pulmonary Drugs Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Pulmonary Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Pulmonary Drugs Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Pulmonary Drugs Sales by Type
        4.1.1 Global Pulmonary Drugs Historical Sales by Type (2017-2022)
        4.1.2 Global Pulmonary Drugs Forecasted Sales by Type (2023-2028)
        4.1.3 Global Pulmonary Drugs Sales Market Share by Type (2017-2028)
    4.2 Global Pulmonary Drugs Revenue by Type
        4.2.1 Global Pulmonary Drugs Historical Revenue by Type (2017-2022)
        4.2.2 Global Pulmonary Drugs Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Pulmonary Drugs Revenue Market Share by Type (2017-2028)
    4.3 Global Pulmonary Drugs Price by Type
        4.3.1 Global Pulmonary Drugs Price by Type (2017-2022)
        4.3.2 Global Pulmonary Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Pulmonary Drugs Sales by Application
        5.1.1 Global Pulmonary Drugs Historical Sales by Application (2017-2022)
        5.1.2 Global Pulmonary Drugs Forecasted Sales by Application (2023-2028)
        5.1.3 Global Pulmonary Drugs Sales Market Share by Application (2017-2028)
    5.2 Global Pulmonary Drugs Revenue by Application
        5.2.1 Global Pulmonary Drugs Historical Revenue by Application (2017-2022)
        5.2.2 Global Pulmonary Drugs Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Pulmonary Drugs Revenue Market Share by Application (2017-2028)
    5.3 Global Pulmonary Drugs Price by Application
        5.3.1 Global Pulmonary Drugs Price by Application (2017-2022)
        5.3.2 Global Pulmonary Drugs Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Pulmonary Drugs Market Size by Type
        6.1.1 North America Pulmonary Drugs Sales by Type (2017-2028)
        6.1.2 North America Pulmonary Drugs Revenue by Type (2017-2028)
    6.2 North America Pulmonary Drugs Market Size by Application
        6.2.1 North America Pulmonary Drugs Sales by Application (2017-2028)
        6.2.2 North America Pulmonary Drugs Revenue by Application (2017-2028)
    6.3 North America Pulmonary Drugs Market Size by Country
        6.3.1 North America Pulmonary Drugs Sales by Country (2017-2028)
        6.3.2 North America Pulmonary Drugs Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Pulmonary Drugs Market Size by Type
        7.1.1 Europe Pulmonary Drugs Sales by Type (2017-2028)
        7.1.2 Europe Pulmonary Drugs Revenue by Type (2017-2028)
    7.2 Europe Pulmonary Drugs Market Size by Application
        7.2.1 Europe Pulmonary Drugs Sales by Application (2017-2028)
        7.2.2 Europe Pulmonary Drugs Revenue by Application (2017-2028)
    7.3 Europe Pulmonary Drugs Market Size by Country
        7.3.1 Europe Pulmonary Drugs Sales by Country (2017-2028)
        7.3.2 Europe Pulmonary Drugs Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Pulmonary Drugs Market Size by Type
        8.1.1 Asia Pacific Pulmonary Drugs Sales by Type (2017-2028)
        8.1.2 Asia Pacific Pulmonary Drugs Revenue by Type (2017-2028)
    8.2 Asia Pacific Pulmonary Drugs Market Size by Application
        8.2.1 Asia Pacific Pulmonary Drugs Sales by Application (2017-2028)
        8.2.2 Asia Pacific Pulmonary Drugs Revenue by Application (2017-2028)
    8.3 Asia Pacific Pulmonary Drugs Market Size by Region
        8.3.1 Asia Pacific Pulmonary Drugs Sales by Region (2017-2028)
        8.3.2 Asia Pacific Pulmonary Drugs Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Pulmonary Drugs Market Size by Type
        9.1.1 Latin America Pulmonary Drugs Sales by Type (2017-2028)
        9.1.2 Latin America Pulmonary Drugs Revenue by Type (2017-2028)
    9.2 Latin America Pulmonary Drugs Market Size by Application
        9.2.1 Latin America Pulmonary Drugs Sales by Application (2017-2028)
        9.2.2 Latin America Pulmonary Drugs Revenue by Application (2017-2028)
    9.3 Latin America Pulmonary Drugs Market Size by Country
        9.3.1 Latin America Pulmonary Drugs Sales by Country (2017-2028)
        9.3.2 Latin America Pulmonary Drugs Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Pulmonary Drugs Market Size by Type
        10.1.1 Middle East and Africa Pulmonary Drugs Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Pulmonary Drugs Revenue by Type (2017-2028)
    10.2 Middle East and Africa Pulmonary Drugs Market Size by Application
        10.2.1 Middle East and Africa Pulmonary Drugs Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Pulmonary Drugs Revenue by Application (2017-2028)
    10.3 Middle East and Africa Pulmonary Drugs Market Size by Country
        10.3.1 Middle East and Africa Pulmonary Drugs Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Pulmonary Drugs Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Sanofi SA
        11.1.1 Sanofi SA Corporation Information
        11.1.2 Sanofi SA Overview
        11.1.3 Sanofi SA Pulmonary Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Sanofi SA Pulmonary Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Sanofi SA Recent Developments
    11.2 Meda Pharmaceuticals
        11.2.1 Meda Pharmaceuticals Corporation Information
        11.2.2 Meda Pharmaceuticals Overview
        11.2.3 Meda Pharmaceuticals Pulmonary Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Meda Pharmaceuticals Pulmonary Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Meda Pharmaceuticals Recent Developments
    11.3 Circassia Pharmaceuticals Plc.
        11.3.1 Circassia Pharmaceuticals Plc. Corporation Information
        11.3.2 Circassia Pharmaceuticals Plc. Overview
        11.3.3 Circassia Pharmaceuticals Plc. Pulmonary Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Circassia Pharmaceuticals Plc. Pulmonary Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Circassia Pharmaceuticals Plc. Recent Developments
    11.4 AstraZeneca Plc.
        11.4.1 AstraZeneca Plc. Corporation Information
        11.4.2 AstraZeneca Plc. Overview
        11.4.3 AstraZeneca Plc. Pulmonary Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 AstraZeneca Plc. Pulmonary Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 AstraZeneca Plc. Recent Developments
    11.5 GlaxoSmithKline Plc.
        11.5.1 GlaxoSmithKline Plc. Corporation Information
        11.5.2 GlaxoSmithKline Plc. Overview
        11.5.3 GlaxoSmithKline Plc. Pulmonary Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 GlaxoSmithKline Plc. Pulmonary Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 GlaxoSmithKline Plc. Recent Developments
    11.6 Mallinckrodt Pharmaceuticals Plc.
        11.6.1 Mallinckrodt Pharmaceuticals Plc. Corporation Information
        11.6.2 Mallinckrodt Pharmaceuticals Plc. Overview
        11.6.3 Mallinckrodt Pharmaceuticals Plc. Pulmonary Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Mallinckrodt Pharmaceuticals Plc. Pulmonary Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Mallinckrodt Pharmaceuticals Plc. Recent Developments
    11.7 Cheisi Farmaceutici S.p.A
        11.7.1 Cheisi Farmaceutici S.p.A Corporation Information
        11.7.2 Cheisi Farmaceutici S.p.A Overview
        11.7.3 Cheisi Farmaceutici S.p.A Pulmonary Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Cheisi Farmaceutici S.p.A Pulmonary Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Cheisi Farmaceutici S.p.A Recent Developments
    11.8 Zambon Company S.p.A
        11.8.1 Zambon Company S.p.A Corporation Information
        11.8.2 Zambon Company S.p.A Overview
        11.8.3 Zambon Company S.p.A Pulmonary Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Zambon Company S.p.A Pulmonary Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Zambon Company S.p.A Recent Developments
    11.9 Alaxia SAS
        11.9.1 Alaxia SAS Corporation Information
        11.9.2 Alaxia SAS Overview
        11.9.3 Alaxia SAS Pulmonary Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Alaxia SAS Pulmonary Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Alaxia SAS Recent Developments
    11.10 Merck Sharp & Dohme Limited
        11.10.1 Merck Sharp & Dohme Limited Corporation Information
        11.10.2 Merck Sharp & Dohme Limited Overview
        11.10.3 Merck Sharp & Dohme Limited Pulmonary Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Merck Sharp & Dohme Limited Pulmonary Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Merck Sharp & Dohme Limited Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Pulmonary Drugs Industry Chain Analysis
    12.2 Pulmonary Drugs Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Pulmonary Drugs Production Mode & Process
    12.4 Pulmonary Drugs Sales and Marketing
        12.4.1 Pulmonary Drugs Sales Channels
        12.4.2 Pulmonary Drugs Distributors
    12.5 Pulmonary Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Pulmonary Drugs Industry Trends
    13.2 Pulmonary Drugs Market Drivers
    13.3 Pulmonary Drugs Market Challenges
    13.4 Pulmonary Drugs Market Restraints
14 Key Findings in The Global Pulmonary Drugs Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Pulmonary Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Inhaled Corticosteroids
    Table 3. Major Manufacturers of Long Acting Beta-2 Agonists
    Table 4. Major Manufacturers of Antihistamines
    Table 5. Major Manufacturers of Vasodilators
    Table 6. Major Manufacturers of Others
    Table 7. Global Pulmonary Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Pulmonary Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 9. Global Pulmonary Drugs Sales by Region (2017-2022) & (K Units)
    Table 10. Global Pulmonary Drugs Sales Market Share by Region (2017-2022)
    Table 11. Global Pulmonary Drugs Sales by Region (2023-2028) & (K Units)
    Table 12. Global Pulmonary Drugs Sales Market Share by Region (2023-2028)
    Table 13. Global Pulmonary Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 14. Global Pulmonary Drugs Revenue Market Share by Region (2017-2022)
    Table 15. Global Pulmonary Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 16. Global Pulmonary Drugs Revenue Market Share by Region (2023-2028)
    Table 17. Global Pulmonary Drugs Sales by Manufacturers (2017-2022) & (K Units)
    Table 18. Global Pulmonary Drugs Sales Share by Manufacturers (2017-2022)
    Table 19. Global Pulmonary Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 20. Global Pulmonary Drugs Revenue Share by Manufacturers (2017-2022)
    Table 21. Pulmonary Drugs Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 22. Global Pulmonary Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Pulmonary Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pulmonary Drugs as of 2021)
    Table 24. Pulmonary Drugs Manufacturing Base Distribution and Headquarters
    Table 25. Manufacturers Pulmonary Drugs Product Offered
    Table 26. Date of Manufacturers Enter into Pulmonary Drugs Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Pulmonary Drugs Sales by Type (2017-2022) & (K Units)
    Table 29. Global Pulmonary Drugs Sales by Type (2023-2028) & (K Units)
    Table 30. Global Pulmonary Drugs Sales Share by Type (2017-2022)
    Table 31. Global Pulmonary Drugs Sales Share by Type (2023-2028)
    Table 32. Global Pulmonary Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 33. Global Pulmonary Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 34. Global Pulmonary Drugs Revenue Share by Type (2017-2022)
    Table 35. Global Pulmonary Drugs Revenue Share by Type (2023-2028)
    Table 36. Pulmonary Drugs Price by Type (2017-2022) & (USD/Unit)
    Table 37. Global Pulmonary Drugs Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 38. Global Pulmonary Drugs Sales by Application (2017-2022) & (K Units)
    Table 39. Global Pulmonary Drugs Sales by Application (2023-2028) & (K Units)
    Table 40. Global Pulmonary Drugs Sales Share by Application (2017-2022)
    Table 41. Global Pulmonary Drugs Sales Share by Application (2023-2028)
    Table 42. Global Pulmonary Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 43. Global Pulmonary Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 44. Global Pulmonary Drugs Revenue Share by Application (2017-2022)
    Table 45. Global Pulmonary Drugs Revenue Share by Application (2023-2028)
    Table 46. Pulmonary Drugs Price by Application (2017-2022) & (USD/Unit)
    Table 47. Global Pulmonary Drugs Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 48. North America Pulmonary Drugs Sales by Type (2017-2022) & (K Units)
    Table 49. North America Pulmonary Drugs Sales by Type (2023-2028) & (K Units)
    Table 50. North America Pulmonary Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 51. North America Pulmonary Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 52. North America Pulmonary Drugs Sales by Application (2017-2022) & (K Units)
    Table 53. North America Pulmonary Drugs Sales by Application (2023-2028) & (K Units)
    Table 54. North America Pulmonary Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 55. North America Pulmonary Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 56. North America Pulmonary Drugs Sales by Country (2017-2022) & (K Units)
    Table 57. North America Pulmonary Drugs Sales by Country (2023-2028) & (K Units)
    Table 58. North America Pulmonary Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 59. North America Pulmonary Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 60. Europe Pulmonary Drugs Sales by Type (2017-2022) & (K Units)
    Table 61. Europe Pulmonary Drugs Sales by Type (2023-2028) & (K Units)
    Table 62. Europe Pulmonary Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 63. Europe Pulmonary Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 64. Europe Pulmonary Drugs Sales by Application (2017-2022) & (K Units)
    Table 65. Europe Pulmonary Drugs Sales by Application (2023-2028) & (K Units)
    Table 66. Europe Pulmonary Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 67. Europe Pulmonary Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 68. Europe Pulmonary Drugs Sales by Country (2017-2022) & (K Units)
    Table 69. Europe Pulmonary Drugs Sales by Country (2023-2028) & (K Units)
    Table 70. Europe Pulmonary Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 71. Europe Pulmonary Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 72. Asia Pacific Pulmonary Drugs Sales by Type (2017-2022) & (K Units)
    Table 73. Asia Pacific Pulmonary Drugs Sales by Type (2023-2028) & (K Units)
    Table 74. Asia Pacific Pulmonary Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 75. Asia Pacific Pulmonary Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 76. Asia Pacific Pulmonary Drugs Sales by Application (2017-2022) & (K Units)
    Table 77. Asia Pacific Pulmonary Drugs Sales by Application (2023-2028) & (K Units)
    Table 78. Asia Pacific Pulmonary Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 79. Asia Pacific Pulmonary Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 80. Asia Pacific Pulmonary Drugs Sales by Region (2017-2022) & (K Units)
    Table 81. Asia Pacific Pulmonary Drugs Sales by Region (2023-2028) & (K Units)
    Table 82. Asia Pacific Pulmonary Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 83. Asia Pacific Pulmonary Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 84. Latin America Pulmonary Drugs Sales by Type (2017-2022) & (K Units)
    Table 85. Latin America Pulmonary Drugs Sales by Type (2023-2028) & (K Units)
    Table 86. Latin America Pulmonary Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 87. Latin America Pulmonary Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 88. Latin America Pulmonary Drugs Sales by Application (2017-2022) & (K Units)
    Table 89. Latin America Pulmonary Drugs Sales by Application (2023-2028) & (K Units)
    Table 90. Latin America Pulmonary Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 91. Latin America Pulmonary Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 92. Latin America Pulmonary Drugs Sales by Country (2017-2022) & (K Units)
    Table 93. Latin America Pulmonary Drugs Sales by Country (2023-2028) & (K Units)
    Table 94. Latin America Pulmonary Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 95. Latin America Pulmonary Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 96. Middle East and Africa Pulmonary Drugs Sales by Type (2017-2022) & (K Units)
    Table 97. Middle East and Africa Pulmonary Drugs Sales by Type (2023-2028) & (K Units)
    Table 98. Middle East and Africa Pulmonary Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 99. Middle East and Africa Pulmonary Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 100. Middle East and Africa Pulmonary Drugs Sales by Application (2017-2022) & (K Units)
    Table 101. Middle East and Africa Pulmonary Drugs Sales by Application (2023-2028) & (K Units)
    Table 102. Middle East and Africa Pulmonary Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 103. Middle East and Africa Pulmonary Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 104. Middle East and Africa Pulmonary Drugs Sales by Country (2017-2022) & (K Units)
    Table 105. Middle East and Africa Pulmonary Drugs Sales by Country (2023-2028) & (K Units)
    Table 106. Middle East and Africa Pulmonary Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 107. Middle East and Africa Pulmonary Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 108. Sanofi SA Corporation Information
    Table 109. Sanofi SA Description and Major Businesses
    Table 110. Sanofi SA Pulmonary Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 111. Sanofi SA Pulmonary Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Sanofi SA Recent Developments
    Table 113. Meda Pharmaceuticals Corporation Information
    Table 114. Meda Pharmaceuticals Description and Major Businesses
    Table 115. Meda Pharmaceuticals Pulmonary Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 116. Meda Pharmaceuticals Pulmonary Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. Meda Pharmaceuticals Recent Developments
    Table 118. Circassia Pharmaceuticals Plc. Corporation Information
    Table 119. Circassia Pharmaceuticals Plc. Description and Major Businesses
    Table 120. Circassia Pharmaceuticals Plc. Pulmonary Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 121. Circassia Pharmaceuticals Plc. Pulmonary Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. Circassia Pharmaceuticals Plc. Recent Developments
    Table 123. AstraZeneca Plc. Corporation Information
    Table 124. AstraZeneca Plc. Description and Major Businesses
    Table 125. AstraZeneca Plc. Pulmonary Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 126. AstraZeneca Plc. Pulmonary Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. AstraZeneca Plc. Recent Developments
    Table 128. GlaxoSmithKline Plc. Corporation Information
    Table 129. GlaxoSmithKline Plc. Description and Major Businesses
    Table 130. GlaxoSmithKline Plc. Pulmonary Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 131. GlaxoSmithKline Plc. Pulmonary Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. GlaxoSmithKline Plc. Recent Developments
    Table 133. Mallinckrodt Pharmaceuticals Plc. Corporation Information
    Table 134. Mallinckrodt Pharmaceuticals Plc. Description and Major Businesses
    Table 135. Mallinckrodt Pharmaceuticals Plc. Pulmonary Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 136. Mallinckrodt Pharmaceuticals Plc. Pulmonary Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. Mallinckrodt Pharmaceuticals Plc. Recent Developments
    Table 138. Cheisi Farmaceutici S.p.A Corporation Information
    Table 139. Cheisi Farmaceutici S.p.A Description and Major Businesses
    Table 140. Cheisi Farmaceutici S.p.A Pulmonary Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 141. Cheisi Farmaceutici S.p.A Pulmonary Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 142. Cheisi Farmaceutici S.p.A Recent Developments
    Table 143. Zambon Company S.p.A Corporation Information
    Table 144. Zambon Company S.p.A Description and Major Businesses
    Table 145. Zambon Company S.p.A Pulmonary Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 146. Zambon Company S.p.A Pulmonary Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 147. Zambon Company S.p.A Recent Developments
    Table 148. Alaxia SAS Corporation Information
    Table 149. Alaxia SAS Description and Major Businesses
    Table 150. Alaxia SAS Pulmonary Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 151. Alaxia SAS Pulmonary Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 152. Alaxia SAS Recent Developments
    Table 153. Merck Sharp & Dohme Limited Corporation Information
    Table 154. Merck Sharp & Dohme Limited Description and Major Businesses
    Table 155. Merck Sharp & Dohme Limited Pulmonary Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 156. Merck Sharp & Dohme Limited Pulmonary Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 157. Merck Sharp & Dohme Limited Recent Developments
    Table 158. Key Raw Materials Lists
    Table 159. Raw Materials Key Suppliers Lists
    Table 160. Pulmonary Drugs Distributors List
    Table 161. Pulmonary Drugs Customers List
    Table 162. Pulmonary Drugs Market Trends
    Table 163. Pulmonary Drugs Market Drivers
    Table 164. Pulmonary Drugs Market Challenges
    Table 165. Pulmonary Drugs Market Restraints
    Table 166. Research Programs/Design for This Report
    Table 167. Key Data Information from Secondary Sources
    Table 168. Key Data Information from Primary Sources
List of Figures
    Figure 1. Pulmonary Drugs Product Picture
    Figure 3. Global Pulmonary Drugs Market Share by Type in 2021 & 2028
    Figure 3. Inhaled Corticosteroids Product Picture
    Figure 4. Long Acting Beta-2 Agonists Product Picture
    Figure 5. Antihistamines Product Picture
    Figure 6. Vasodilators Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global Pulmonary Drugs Market Share by Application in 2021 & 2028
    Figure 9. Asthma & COPD
    Figure 10. Allergic Rhinitis
    Figure 11. Pulmonary Arterial Hypertension
    Figure 12. Cystic Fibrosis
    Figure 13. Others
    Figure 14. Pulmonary Drugs Report Years Considered
    Figure 15. Global Pulmonary Drugs Sales 2017-2028 (K Units)
    Figure 16. Global Pulmonary Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 17. Global Pulmonary Drugs Revenue 2017-2028 (US$ Million)
    Figure 18. Global Pulmonary Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 19. Global Pulmonary Drugs Sales Market Share by Region (2017-2022)
    Figure 20. Global Pulmonary Drugs Sales Market Share by Region (2023-2028)
    Figure 21. North America Pulmonary Drugs Sales YoY (2017-2028) & (K Units)
    Figure 22. North America Pulmonary Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Europe Pulmonary Drugs Sales YoY (2017-2028) & (K Units)
    Figure 24. Europe Pulmonary Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Asia-Pacific Pulmonary Drugs Sales YoY (2017-2028) & (K Units)
    Figure 26. Asia-Pacific Pulmonary Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Latin America Pulmonary Drugs Sales YoY (2017-2028) & (K Units)
    Figure 28. Latin America Pulmonary Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. Middle East & Africa Pulmonary Drugs Sales YoY (2017-2028) & (K Units)
    Figure 30. Middle East & Africa Pulmonary Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 31. The Pulmonary Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 32. The Top 5 and 10 Largest Manufacturers of Pulmonary Drugs in the World: Market Share by Pulmonary Drugs Revenue in 2021
    Figure 33. Global Pulmonary Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 34. Global Pulmonary Drugs Sales Market Share by Type (2017-2028)
    Figure 35. Global Pulmonary Drugs Revenue Market Share by Type (2017-2028)
    Figure 36. Global Pulmonary Drugs Sales Market Share by Application (2017-2028)
    Figure 37. Global Pulmonary Drugs Revenue Market Share by Application (2017-2028)
    Figure 38. North America Pulmonary Drugs Sales Market Share by Type (2017-2028)
    Figure 39. North America Pulmonary Drugs Revenue Market Share by Type (2017-2028)
    Figure 40. North America Pulmonary Drugs Sales Market Share by Application (2017-2028)
    Figure 41. North America Pulmonary Drugs Revenue Market Share by Application (2017-2028)
    Figure 42. North America Pulmonary Drugs Sales Share by Country (2017-2028)
    Figure 43. North America Pulmonary Drugs Revenue Share by Country (2017-2028)
    Figure 44. U.S. Pulmonary Drugs Revenue (2017-2028) & (US$ Million)
    Figure 45. Canada Pulmonary Drugs Revenue (2017-2028) & (US$ Million)
    Figure 46. Europe Pulmonary Drugs Sales Market Share by Type (2017-2028)
    Figure 47. Europe Pulmonary Drugs Revenue Market Share by Type (2017-2028)
    Figure 48. Europe Pulmonary Drugs Sales Market Share by Application (2017-2028)
    Figure 49. Europe Pulmonary Drugs Revenue Market Share by Application (2017-2028)
    Figure 50. Europe Pulmonary Drugs Sales Share by Country (2017-2028)
    Figure 51. Europe Pulmonary Drugs Revenue Share by Country (2017-2028)
    Figure 52. Germany Pulmonary Drugs Revenue (2017-2028) & (US$ Million)
    Figure 53. France Pulmonary Drugs Revenue (2017-2028) & (US$ Million)
    Figure 54. U.K. Pulmonary Drugs Revenue (2017-2028) & (US$ Million)
    Figure 55. Italy Pulmonary Drugs Revenue (2017-2028) & (US$ Million)
    Figure 56. Russia Pulmonary Drugs Revenue (2017-2028) & (US$ Million)
    Figure 57. Asia Pacific Pulmonary Drugs Sales Market Share by Type (2017-2028)
    Figure 58. Asia Pacific Pulmonary Drugs Revenue Market Share by Type (2017-2028)
    Figure 59. Asia Pacific Pulmonary Drugs Sales Market Share by Application (2017-2028)
    Figure 60. Asia Pacific Pulmonary Drugs Revenue Market Share by Application (2017-2028)
    Figure 61. Asia Pacific Pulmonary Drugs Sales Share by Region (2017-2028)
    Figure 62. Asia Pacific Pulmonary Drugs Revenue Share by Region (2017-2028)
    Figure 63. China Pulmonary Drugs Revenue (2017-2028) & (US$ Million)
    Figure 64. Japan Pulmonary Drugs Revenue (2017-2028) & (US$ Million)
    Figure 65. South Korea Pulmonary Drugs Revenue (2017-2028) & (US$ Million)
    Figure 66. India Pulmonary Drugs Revenue (2017-2028) & (US$ Million)
    Figure 67. Australia Pulmonary Drugs Revenue (2017-2028) & (US$ Million)
    Figure 68. Taiwan Pulmonary Drugs Revenue (2017-2028) & (US$ Million)
    Figure 69. Indonesia Pulmonary Drugs Revenue (2017-2028) & (US$ Million)
    Figure 70. Thailand Pulmonary Drugs Revenue (2017-2028) & (US$ Million)
    Figure 71. Malaysia Pulmonary Drugs Revenue (2017-2028) & (US$ Million)
    Figure 72. Philippines Pulmonary Drugs Revenue (2017-2028) & (US$ Million)
    Figure 73. Latin America Pulmonary Drugs Sales Market Share by Type (2017-2028)
    Figure 74. Latin America Pulmonary Drugs Revenue Market Share by Type (2017-2028)
    Figure 75. Latin America Pulmonary Drugs Sales Market Share by Application (2017-2028)
    Figure 76. Latin America Pulmonary Drugs Revenue Market Share by Application (2017-2028)
    Figure 77. Latin America Pulmonary Drugs Sales Share by Country (2017-2028)
    Figure 78. Latin America Pulmonary Drugs Revenue Share by Country (2017-2028)
    Figure 79. Mexico Pulmonary Drugs Revenue (2017-2028) & (US$ Million)
    Figure 80. Brazil Pulmonary Drugs Revenue (2017-2028) & (US$ Million)
    Figure 81. Argentina Pulmonary Drugs Revenue (2017-2028) & (US$ Million)
    Figure 82. Middle East and Africa Pulmonary Drugs Sales Market Share by Type (2017-2028)
    Figure 83. Middle East and Africa Pulmonary Drugs Revenue Market Share by Type (2017-2028)
    Figure 84. Middle East and Africa Pulmonary Drugs Sales Market Share by Application (2017-2028)
    Figure 85. Middle East and Africa Pulmonary Drugs Revenue Market Share by Application (2017-2028)
    Figure 86. Middle East and Africa Pulmonary Drugs Sales Share by Country (2017-2028)
    Figure 87. Middle East and Africa Pulmonary Drugs Revenue Share by Country (2017-2028)
    Figure 88. Turkey Pulmonary Drugs Revenue (2017-2028) & (US$ Million)
    Figure 89. Saudi Arabia Pulmonary Drugs Revenue (2017-2028) & (US$ Million)
    Figure 90. U.A.E Pulmonary Drugs Revenue (2017-2028) & (US$ Million)
    Figure 91. Pulmonary Drugs Value Chain
    Figure 92. Pulmonary Drugs Production Process
    Figure 93. Channels of Distribution
    Figure 94. Distributors Profiles
    Figure 95. Bottom-up and Top-down Approaches for This Report
    Figure 96. Data Triangulation
    Figure 97. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Sanofi SA
Meda Pharmaceuticals
Circassia Pharmaceuticals Plc.
AstraZeneca Plc.
GlaxoSmithKline Plc.
Mallinckrodt Pharmaceuticals Plc.
Cheisi Farmaceutici S.p.A
Zambon Company S.p.A
Alaxia SAS
Merck Sharp & Dohme Limited
Frequently Asked Questions
Pulmonary Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Pulmonary Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Pulmonary Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Rx Medical Food

Rx Medical Food market is segmented by Type and by Application. Players, stakeholders, and other  ... Read More

Salt Substitutes

Salt Substitutes market is segmented by Type and by Application. Players, stakeholders, and other ... Read More